Search

Author/Creator DiBattiste, Peter M.

1. Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention. Issue 1 (22nd November 2022)

Authors:
Vilain, Katherine A.; DiBattiste, Peter M.; Schneider, David J.; Cohen, David J.
Journal:
Coronary artery disease
Issue:
Volume 34:Issue 1(2023)
Page Start:
24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis. (13th October 2019)

Authors:
Weitz, Jeffrey I.; Segers, Annelise; Raskob, Gary; Roberts, Robin S.; Francis, Charles; Lassen, Michael Rud; Fuji, Takeshi; Swaim, Renée M.; Lee, Michael; Peters, Gary; DiBattiste, Peter M.; Tesfaye, Fisseha; Strony, John
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 17:Number 12(2019)
Page Start:
2081
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions. (23rd May 2013)

Authors:
Sarich, Troy C.; Peters, Gary; Berkowitz, Scott D.; Misselwitz, Frank; Nessel, Christopher C.; Burton, Paul; Cook‐Bruns, Nancy; Lensing, Anthonie W.A.; Haskell, Lloyd; Perzborn, Elisabeth; Kubitza, Dagmar; Moore, Kenneth T.; Jalota, Sanjay; Weber, Juergen; Pan, Guohua; Sun, Xiang; Westermeier, To...
Journal:
Annals of the New York Academy of Sciences
Issue:
Volume 1291(2013)
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗